ConductScience.org, home

Paper1752455

Healing and prevention of relapse of reflux oesophagitis by cisapride.

Toussaint J and 4 others. Gut, 1991. Cited by 73 papers, by iCite.

Cite this record

ConductScience Library. Healing and prevention of relapse of reflux oesophagitis by cisapride. Papers, record 1752455. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1752455

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Healing and prevention of relapse of reflux oesophagitis by cisapride.
PubMed
Journal
Gut
PubMed
Year
1991
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
73
iCite
Relative citation ratio, by iCite
4.85
iCite
Revised in PubMed
2019-05-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Toussaint JJ
2Gossuin AA
3Deruyttere MM
4Hublé FF
5Devis GG

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Esophagitis, PepticMajor topic
PiperidinesMajor topic
Adolescent
Adult
Aged
Cisapride
Double-Blind Method
Esophagus
Female
Humans
Male
Middle Aged
Prospective Studies
Recurrence
Remission Induction

Source PubMed

Download CSV of topics

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12491462Review article: a role for gastrointestinal prokinetic agents in the treatment of reflux oesophagitis?Aliment Pharmacol Ther1989https://conductscience.org/library/papers/2491462PubMed
22906465Treatment of reflux oesophagitis with H2-receptor antagonists.Scand J Gastroenterol Suppl1988https://conductscience.org/library/papers/2906465PubMed
33065057Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders.Drugs1988https://conductscience.org/library/papers/3065057PubMed
42898983Pharmacological bases of the medical treatment of gastroesophageal reflux disease.Dig Dis1988https://conductscience.org/library/papers/2898983PubMed
53181682Efficacy of chenodeoxycholic acid and ursodeoxycholic acid for lowering cholesterol saturation index of gallbladder in patients with a sphincterotomy.Gastroenterology1988https://conductscience.org/library/papers/3181682PubMed
63310197The effects of omeprazole on gastro-oesophageal sphincter pressure, intragastric pH, and the migrating motor complex in fasting healthy subjects.Scand J Gastroenterol1987https://conductscience.org/library/papers/3310197PubMed
73530865Healing and relapse of reflux esophagitis during treatment with ranitidine.Gastroenterology1986https://conductscience.org/library/papers/3530865PubMed
86508988The effect of omeprazole on gastric emptying in patients with duodenal ulcer disease.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6508988PubMed
93520794Gastroesophageal reflux disease. Acute and maintenance treatments with cimetidine.Scand J Gastroenterol1986https://conductscience.org/library/papers/3520794PubMed
103666562H2 antagonists in the treatment of reflux oesophagitis: can physiological studies predict the response?Gut1987https://conductscience.org/library/papers/3666562PubMed
116133814Gastro-oesophageal function in normal subjects after oral administration of ranitidine.Gut1983https://conductscience.org/library/papers/6133814PubMed
126321588Ranitidine in the treatment of symptomatic gastroesophageal reflux disease.J Clin Gastroenterol1984https://conductscience.org/library/papers/6321588PubMed
137007900Cimetidine in the treatment of severe ulcerative reflux oesophagitis; results of an 8-week double-blind study and of subsequent long-term maintenance treatment.Neth J Med1980https://conductscience.org/library/papers/7007900PubMed
14357977Drug therapy: Cimetidine.N Engl J Med1978https://conductscience.org/library/papers/357977PubMed
15340333Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial.Gastroenterology1978https://conductscience.org/library/papers/340333PubMed
163042576Cisapride versus ranitidine in the treatment of reflux esophagitis.Hepatogastroenterology1988https://conductscience.org/library/papers/3042576PubMed
172896523The medical therapy of reflux oesophagitis.Baillieres Clin Gastroenterol1987https://conductscience.org/library/papers/2896523PubMed
183068300Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial.J Clin Gastroenterol1988https://conductscience.org/library/papers/3068300PubMed
193090134Clinical relevance of gastroduodenal dysfunction in reflux esophagitis.J Clin Gastroenterol1986https://conductscience.org/library/papers/3090134PubMed
203535012Effect of the prokinetic drug cisapride on gastrointestinal hormone release.Scand J Gastroenterol1986https://conductscience.org/library/papers/3535012PubMed

See all 28 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.

PMIDTitleJournalYearIn PapersSource
18370513Meta-Analyses of Cisapride, Omeprazole and Ranitidine in the Treatment of GORD: Implications for Treating Patient Subgroups.Clin Drug Investig1998https://conductscience.org/library/papers/18370513PubMed
15082617A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials.Gut2004https://conductscience.org/library/papers/15082617PubMed
12509687A rational approach to uninvestigated dyspepsia in primary care: review of the literature.Postgrad Med J2002https://conductscience.org/library/papers/12509687PubMed
10946415Role of drug therapy in the treatment of gastro-oesophageal reflux disorder in children.Paediatr Drugs2000https://conductscience.org/library/papers/10946415PubMed
8527013A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders.Drug Saf1995https://conductscience.org/library/papers/8527013PubMed
8444088Effect of cisapride on relapse of esophagitis. A multinational, placebo-controlled trial in patients healed with an antisecretory drug. The Italian Eurocis Trialists.Dig Dis Sci1993https://conductscience.org/library/papers/8444088PubMed
8174947Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.Gut1993https://conductscience.org/library/papers/8174947PubMed
7601011Pharmacological management of gastro-oesophageal reflux disease.Drugs1995https://conductscience.org/library/papers/7601011PubMed
7510617Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.Drugs1994https://conductscience.org/library/papers/7510617PubMed
7502532The knife or the pill in the long-term treatment of gastroesophageal reflux disease?Yale J Biol Med1994https://conductscience.org/library/papers/7502532PubMed
1348594Maintenance therapy: is there still a place for antireflux surgery?World J Surg1992https://conductscience.org/library/papers/1348594PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1752455

GET https://conductscience.org/api/papers/v1/1752455/references?page=2